Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2016 1
2017 2
2018 1
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Citations

4 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D'Hoore A, Diaz-Rubio E, Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Köhne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K, Normanno N, Österlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Taïeb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D. Van Cutsem E, et al. Ann Oncol. 2016 Aug;27(8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5. Ann Oncol. 2016. PMID: 27380959 Free article.
Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients with metastatic CRC (mCRC) has improved greatly due not only to an increas
Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last deca
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer.
Yoshino T, Cervantes A, Bando H, Martinelli E, Oki E, Xu RH, Mulansari NA, Govind Babu K, Lee MA, Tan CK, Cornelio G, Chong DQ, Chen LT, Tanasanvimon S, Prasongsook N, Yeh KH, Chua C, Sacdalan MD, Sow Jenson WJ, Kim ST, Chacko RT, Syaiful RA, Zhang SZ, Curigliano G, Mishima S, Nakamura Y, Ebi H, Sunakawa Y, Takahashi M, Baba E, Peters S, Ishioka C, Pentheroudakis G. Yoshino T, et al. ESMO Open. 2023 Jun;8(3):101558. doi: 10.1016/j.esmoop.2023.101558. Epub 2023 May 24. ESMO Open. 2023. PMID: 37236086 Free PMC article.
The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer (mCRC), published in late 2022, were adapted in December 2022, accordin …
The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of …
Practical notes on the current ESMO consensus guidelines for the management of patients with metastatic colorectal cancer in resource-constrained environments of low- to middle-income countries.
Maurel JM, Tamayo MB, Pitargue R, Ong-Cornel AB, Mehta P, Diouf D, Deshmukh C, Basade M, Balde S, Adanza-Cutillar E, Dawood S. Maurel JM, et al. Oncology. 2023 Mar 23;101(1):5-8. doi: 10.1159/000530275. Online ahead of print. Oncology. 2023. PMID: 36958305 Free PMC article.
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.
Yoshino T, Arnold D, Taniguchi H, Pentheroudakis G, Yamazaki K, Xu RH, Kim TW, Ismail F, Tan IB, Yeh KH, Grothey A, Zhang S, Ahn JB, Mastura MY, Chong D, Chen LT, Kopetz S, Eguchi-Nakajima T, Ebi H, Ohtsu A, Cervantes A, Muro K, Tabernero J, Minami H, Ciardiello F, Douillard JY. Yoshino T, et al. Ann Oncol. 2018 Jan 1;29(1):44-70. doi: 10.1093/annonc/mdx738. Ann Oncol. 2018. PMID: 29155929 Free article.
The most recent version of the European Society for Medical Oncology (ESMO) consensus guidelines for the treatment of patients with metastatic colorectal cancer (mCRC) was published in 2016, identifying both a more strategic approa …
The most recent version of the European Society for Medical Oncology (ESMO) consensus guidelines for the treatment of …
Colorectal Cancer and the Obese Patient: A Call for Guidelines.
Petrou NA, Rafique H, Rasheed S, Tekkis P, Kontovounisios C. Petrou NA, et al. Cancers (Basel). 2022 Oct 26;14(21):5255. doi: 10.3390/cancers14215255. Cancers (Basel). 2022. PMID: 36358674 Free PMC article.
The link between obesity and colorectal cancer has been well established. The worldwide rise in obesity rates in the past 40 years means that we are dealing with increasing numbers of obese patients with colorectal cancer. We aimed to review the …
The link between obesity and colorectal cancer has been well established. The worldwide rise in obesity rates in the past 40 y …
Role of Thermal Ablation in Colorectal Cancer Lung Metastases.
Delpla A, de Baere T, Varin E, Deschamps F, Roux C, Tselikas L. Delpla A, et al. Cancers (Basel). 2021 Feb 22;13(4):908. doi: 10.3390/cancers13040908. Cancers (Basel). 2021. PMID: 33671510 Free PMC article. Review.
Background: Consensus guidelines of the European Society for Medical Oncology (ESMO) (2016) provided recommendations for the management of lung metastases. ...Conclusions: Thermal ablation of a selected subpopulation of patients with colorect
Background: Consensus guidelines of the European Society for Medical Oncology (ESMO) (2016) provided recommendations fo …
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.
van de Velde CJ, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, Beets-Tan RG, van den Broek CB, Brown G, Van Cutsem E, Espin E, Haustermans K, Glimelius B, Iversen LH, van Krieken JH, Marijnen CA, Henning G, Gore-Booth J, Meldolesi E, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten H, Schmoll HJ, Smith JJ, Tanis PJ, Taylor C, Wibe A, Wiggers T, Gambacorta MA, Aristei C, Valentini V. van de Velde CJ, et al. Eur J Cancer. 2014 Jan;50(1):1.e1-1.e34. doi: 10.1016/j.ejca.2013.06.048. Epub 2013 Oct 31. Eur J Cancer. 2014. PMID: 24183379
BACKGROUND: Care for patients with colon and rectal cancer has improved in the last 20years; however considerable variation still exists in cancer management and outcome between European countries. ...This manuscript covers all sentences of the cons
BACKGROUND: Care for patients with colon and rectal cancer has improved in the last 20years; however considerable variation st …
Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin.
Mauri G, Monfardini L, Garnero A, Zampino MG, Orsi F, Della Vigna P, Bonomo G, Varano GM, Busso M, Gazzera C, Fonio P, Veltri A, Calandri M. Mauri G, et al. Cancers (Basel). 2021 May 26;13(11):2617. doi: 10.3390/cancers13112617. Cancers (Basel). 2021. PMID: 34073585 Free PMC article. Review.
Colorectal cancer (CRC) is the third most common cancer worldwide and has a high rate of metastatic disease which is the main cause of CRC-related death. Oligometastatic disease is a clinical condition recently included in ESMO
Colorectal cancer (CRC) is the third most common cancer worldwide and has a high rate of metastatic disease
Peritoneal metastases of colorectal origin - cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). The financial aspect.
Jastrzębski T, Bębenek M. Jastrzębski T, et al. Pol Przegl Chir. 2017 Dec 30;89(6):1-6. doi: 10.5604/01.3001.0010.6733. Pol Przegl Chir. 2017. PMID: 29335393 Free article.
The incidence of peritoneal carcinomatosis of colorectal cancer amounts to 5%-15% for synchronous metastases and as much as 40% in cases of local recurrence. ...Realistic valuation and reimbursement covering the overall average cost of the procedure is recommended b …
The incidence of peritoneal carcinomatosis of colorectal cancer amounts to 5%-15% for synchronous metastases and as much as 40 …